Target RWE

?? #TargetRWE is excited to announce a major milestone in our strategic partnership with the American Association for the Study of Liver Diseases (AASLD) — the enrollment of over 600,000 patients in the #TARGETLIVERDISEASE (TARGET-LD) observational study! This groundbreaking effort supports the #CirrhosisQualityCollaborative (CQC) and aims to bridge the gap between best practices and current care to improve outcomes for patients living with #cirrhosis and other #chronicliverdiseases. ?? We're proud to continue collaborating with #AASLD to drive meaningful change in the fight against #liverdisease. Learn more today:?https://lnkd.in/gZVkzxqC #RealWorldEvidence #TARGETLD #LiverHealth #MedicalResearch #HealthInnovation #TargetRWE #LiverResearch?#CQC

?? ?? Exciting news from #TargetRWE! One of our latest studies titled, Concordance of #MASLD and #NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort, is one of the first to explore the alignment of the new nomenclature with established diagnostic criteria for #Pediatric patients with metabolic dysfunction-associated steatohepatitis (MASH), formerly known as #NASH. This research confirms the applicability of the new MASLD/MASH terminology in pediatric populations and supports the use of non-invasive clinical data for diagnosing #PediatricMASH. Click the link to read the press release today: https://lnkd.in/gw7Gv6nA #LiverDisease #MASH #TARGETNASH #PediatricHealth #Pediatrics #RealWorldEvidence #MedicalResearch?

?? #TargetRWE is proud to congratulate Pooja Miglani, Sr. Director of Product Management & Marketing, on being nominated for the #WomenInTechGlobalAwards2024! We're thrilled to see Pooja nominated alongside such a distinguished panel. Join us in honoring the achievements of the remarkable women in technology at the awards ceremony on December 4th. See you there! ?? https://lnkd.in/dAz_p7Dy #WomenInTech #TechAwards

???? #ManuscriptMonday! Take a look at #TargetRWE's 2018 study, Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States, highlighting key findings about the use of IV bisphosphonates (IV BPs) in newly diagnosed #MultipleMyeloma (MM) patients. Despite the role of IV BPs in preventing skeletal-related events, we observed that many patients did not initiate treatment as expected, and even more experienced interruptions during the first year of therapy. To learn more about our research, click the link to read the full manuscript here ???? https://lnkd.in/gc3tgVFp #MM #OncologyResearch #RealWorldEvidence #CancerCare #MedicalResearch

#TargetRWE is thrilled to announce that our Senior Vice President Analytics & Data Operations, Ewa J. Kleczyk, PhD MSc, has been nominated as a distinguished member of the #WomeninTechGlobalAwards (WTGA2024) jury! Ewa’s expertise, dedication, and impact in the tech industry make her a perfect fit to help recognize the amazing trailblazers transforming the tech world. Join us in celebrating Ewa and the rest of the incredible jury members, as we look forward to honoring the achievements of women in technology.??? Don’t miss the Awards Ceremony on December 4th: https://lnkd.in/dvhMffs5 #WTGA2024 #WomenInTech #TechAwards #Innovation #Leadership

?? What an incredible experience at our partner’s, the American Association for the Study of Liver Diseases (AASLD), #TheLiverMeeting2024! The team at #TargetRWE was thrilled to be part of this prestigious event, connecting with leaders in #LiverDiseaseResearch and sharing insights on the power of #RealWorldEvidence to transform patient care. We loved engaging with fellow experts, discussing groundbreaking innovations, and exploring new opportunities to improve outcomes for those living with #LiverDisease. It's always inspiring to be surrounded by such a passionate community driving meaningful change in #liverhealth ?? Click the link to learn more about our activity at #TLM2024: https://lnkd.in/eKZ9ERUP #LiverResearch #HealthInnovation #MedicalResearch #TARGETLD #CQC?

??????? In honor of the American Association for the Study of Liver Diseases (AASLD) #TheLiverMeeting starting tomorrow, #TargetRWE is proud to spotlight TARGET-LIVER DISEASE (TARGET-LD), a cutting-edge and collaborative study providing critical #RealWorldData to accelerate research and understanding of #LiverDisease. #TARGETLD integrates diverse patient data to develop insights on disease progression, treatment patterns, and patient outcomes. Click the link to learn more about how TARGET-LD can drive your clinical research program: https://lnkd.in/gnEHgdhV #RealWorldEvidence #RWD #ClinicalResearch #HealthcareInnovation #MedicalResearch #TLM2024 #LiverResearch?

?? ?? #TargetRWE is thrilled to attend the American Association for the Study of Liver Diseases (AASLD) #TheLiverMeeting in San Diego this week. Before the event, check out our video with #TARGETNASH steering committee member, A. Sidney Barritt IV, MD, MSCR, where he presents our study, "Real World Use of GLP-1 Receptor Agonists in Patients with MASLD: A Cross-Sectional Analysis from TARGET-NASH." This presentation highlights the characteristics of #GLP1RA users within the TARGET-NASH cohort. We'll also be sharing additional research on #GLP1 usage in patients with #ChronicLiverDisease at The Liver Meeting. Click the link to learn more about our activity at #TLM2024 ?? https://lnkd.in/eKZ9ERUP #AASLD2024 #MASLD #LiverResearch #NASH #LiverDisease #LiverHealth #RealWorldEvidence #MedicalResearch?

?? ?? #TargetRWE is excited to be attending American Association for the Study of Liver Diseases (AASLD) #TheLiverMeeting this week in San Diego. Prior to the event, check out our video presentation with #TARGETNASH steering committee member, Arun J. Sanyal MBBS, MD, of our study, titled "A Prospective Assessment of Disease Progression Impact on Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease," which highlights the increased burden on patients as #MASLD progresses. We will have two more research presentations at The Liver Meeting featuring the NASH-CHECK PRO and how it affects patients as their condition progresses. Our research is demonstrating the value of #PatientReportedOutcomes in understanding the impact of liver disease. Click the link to learn more about the presentation and our activity at #TLM2024:?https://lnkd.in/eKZ9ERUP #NASH #MASH #Cirrhosis #LiverDisease #LiverHealth #Hepatology #LiverResearch #PROs #RealWorldEvidence?

???Happy #VeteransDay from #TargetRWE! We are proud of and thankful for the courageous men and women who have served in our nation's military. Every day we are grateful for their dedication, resilience, and the invaluable skills they bring to our nation's armed forces. Your service and sacrifice inspire us! #ThankYouForYourService #HappyVeteransDay #Gratitude